세계의 의약품용 카트리지 시장 - 예측(2025-2030년)

The global pharmaceutical cartridge market is expected to grow at a CAGR of 3.23% over the forecast period to reach a total market size of US$3.265 billion by 2030, increasing from US$2.785 billion in 2025.

The pharmaceutical cartridge market is poised for robust growth, driven by escalating demand for contamination-resistant drug packaging solutions and the expanding pharmaceutical sector. Key factors fueling this expansion include the rising global burden of chronic diseases, particularly diabetes, which amplifies the need for insulin delivery systems utilizing pre-fillable cartridges. An aging population, coupled with age-related health conditions, further accelerates market demand. Cartridges are integral to modern drug delivery mechanisms, and their application extends beyond pharmaceuticals to biomedical research and biotechnology, creating additional growth avenues.

Market Drivers

• Diabetes Epidemic: The surge in insulin-dependent diabetes (types 1 and 2) is a primary growth catalyst. In the U.S., over 38 million people live with diabetes (2023 data), with 5%-10% diagnosed with type 1 diabetes (ADA). Globally, diabetes affects approximately 830 million people (WHO, 2022), contributing to severe complications such as cardiovascular disease, kidney failure, and blindness. By 2045, cases are projected to reach 628.6 million (IDF), necessitating advanced insulin delivery solutions like cartridges.
• Aging Population: Age-related chronic diseases and rising healthcare needs among the elderly bolster demand for reliable drug delivery systems.
• Biotech Advancements: Expanding biomedical research and biotech innovation drive cartridge adoption in non-pharmaceutical sectors.

Geographical Trends

• North America: The U.S. dominates the market, supported by high healthcare spending and a mature pharmaceutical industry.
• Asia-Pacific: Emerging as the fastest-growing region, India and China lead due to soaring diabetes rates and healthcare investments. India's healthcare sector reached $372 billion in 2023 (IBEF), with ASEAN nations also contributing to regional growth.

Future Outlook

The convergence of chronic disease prevalence, aging demographics, and biotech advancements positions cartridges as critical components in global healthcare. With diabetes-related mortality claiming 4 million lives annually (IDF), innovations in drug delivery systems will remain pivotal, ensuring sustained market expansion across North America and high-growth Asian economies.

Reasons for buying this report:-

• Insightful Analysis: Gain detailed market insights covering major as well as emerging geographical regions, focusing on customer segments, government policies and socio-economic factors, consumer preferences, industry verticals, other sub- segments.
• Competitive Landscape: Understand the strategic maneuvers employed by key players globally to understand possible market penetration with the correct strategy.
• Market Drivers & Future Trends: Explore the dynamic factors and pivotal market trends and how they will shape up future market developments.
• Actionable Recommendations: Utilize the insights to exercise strategic decision to uncover new business streams and revenues in a dynamic environment.
• Caters to a Wide Audience: Beneficial and cost-effective for startups, research institutions, consultants, SMEs, and large enterprises.

What do businesses use our reports for?

Industry and Market Insights, Opportunity Assessment, Product Demand Forecasting, Market Entry Strategy, Geographical Expansion, Capital Investment Decisions, Regulatory Framework & Implications, New Product Development, Competitive Intelligence

Report Coverage:

• Historical data & forecasts from 2022 to 2030
• Growth Opportunities, Challenges, Supply Chain Outlook, Regulatory Framework, Customer Behaviour, and Trend Analysis
• Competitive Positioning, Strategies, and Market Share Analysis
• Revenue Growth and Forecast Assessment of segments and regions including countries
• Company Profiling (Strategies, Products, Financial Information, and Key Developments among others)

Global Pharmaceutical Cartridge Market has been segmented as following:

By Material

• Glass
• Plastic

By Cartridge Size

• Less than 3ml
• 3ml to 5ml
• 5ml to 10ml
• Greater than 10ml

By End User

• Pharmaceutical Company
• Biotech Company
• Biomedical Research Organization

By Geography

• North America
• USA
• Canada
• Mexico
• South America
• Brazil
• Argentina
• Rest of South America
• Europe
• United Kingdom
• Germany
• France
• Italy
• Spain
• Rest of Europe
• Middle East and Africa
• Saudi Arabia
• UAE
• Rest of the Middle East and Africa
• Asia Pacific
• China
• India
• Japan
• South Korea
• Taiwan
• Thailand
• Indonesia
• Rest of Asia-Pacific

TABLE OF CONTENTS

1. INTRODUCTION

• 1.1. Market Overview
• 1.2. Market Definition
• 1.3. Scope of the Study
• 1.4. Market Segmentation
• 1.5. Currency
• 1.6. Assumptions
• 1.7. Base and Forecast Years Timeline
• 1.8. Key benefits for the stakeholders

2. RESEARCH METHODOLOGY

• 2.1. Research Design
• 2.2. Research Process
• 2.3. Data Validation

3. EXECUTIVE SUMMARY

• 3.1. Key Findings
• 3.2. Analyst View

4. MARKET DYNAMICS

• 4.1. Market Drivers
• 4.2. Market Restraints
• 4.3. Porter's Five Forces Analysis
  • 4.3.1. Bargaining Power of Supplier
  • 4.3.2. Bargaining Power of Buyers
  • 4.3.3. Threat of New Entrants
  • 4.3.4. Threat of Substitutes
  • 4.3.5. Competitive Rivalry in the Industry
• 4.4. Industry Value Chain Analysis

5. GLOBAL PHARMACEUTICAL CARTRIDGE MARKET BY MATERIAL

• 5.1. Introduction
• 5.2. Glass
• 5.3. Plastic

6. GLOBAL PHARMACEUTICAL CARTRIDGE MARKET BY CARTRIDGE SIZE

• 6.1. Introduction
• 6.2. Less than 3ml
• 6.3. 3ml to 5ml
• 6.4. 5ml to 10ml
• 6.5. Greater than 10ml

7. GLOBAL PHARMACEUTICAL CARTRIDGE MARKET BY END-USER

• 7.1. Introduction
• 7.2. Pharmaceutical Company
• 7.3. Biotech Company
• 7.4. Biomedical Research Organization

8. GLOBAL PHARMACEUTICAL CARTRIDGE MARKET BY GEOGRAPHY

• 8.1. Global Overview
• 8.2. North America
  • 8.2.1. United States
  • 8.2.2. Canada
  • 8.2.3. Mexico
• 8.3. South America
  • 8.3.1. Brazil
  • 8.3.2. Argentina
  • 8.3.3. Rest of South America
• 8.4. Europe
  • 8.4.1. United Kingdom
  • 8.4.2. Germany
  • 8.4.3. France
  • 8.4.4. Italy
  • 8.4.5. Spain
  • 8.4.6. Rest of Europe
• 8.5. Middle East and Africa
  • 8.5.1. Saudi Arabia
  • 8.5.2. United Arab Emirates
  • 8.5.3. Rest of the Middle East and Africa
• 8.6. Asia-Pacific
  • 8.6.1. China
  • 8.6.2. India
  • 8.6.3. Japan
  • 8.6.4. South Korea
  • 8.6.5. Taiwan
  • 8.6.6. Thailand
  • 8.6.7. Indonesia
  • 8.6.8. Rest of Asia-Pacific

9. COMPETITIVE ENVIRONMENT AND ANALYSIS

• 9.1. Major Players and Strategy Analysis
• 9.2. Emerging Players and Market Lucrativeness
• 9.3. Mergers, Acquisitions, Agreements, and Collaborations
• 9.4. Competitive Dashboard

10. COMPANY PROFILES

• 10.1. Gerresheimer AG
• 10.2. Stevanato Group
• 10.3. SCHOTT AG
• 10.4. West Pharmaceutical Services, Inc.
• 10.5. Transcoject GmbH
• 10.6. Sigma-Aldrich, Inc.
• 10.7. Nipro Corporation
• 10.8. Datwyler Holding Inc.
• 10.9. Shandong Province Medicinal Glass Co., Ltd.